IMARC Group, a leading market research company, has recently releases report titled, “Acne Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The study provides a detailed analysis of the industry, including the global acne drugs market growth, share, size and trends forecasts. The report also includes competitor and regional analysis and highlights the latest advancements in the market. Report Highlights
How big is the acne drugs market?
Report Attributes | Details |
Market Size in 2022 | US$ 6.5 Billion |
Market Forecast in 2028 | US$ 9.2 Billion |
Growth rate (2023 to 2028) | CAGR of 5.3% |
Base Year of the Analysis | 2022 |
Forecast Period | 2023-2028 |
What is acne drugs?
Acne refers to a common skin condition that occurs when hair follicles become plugged with oil and dead skin cells and cause whiteheads, blackheads, lumps, and pimples. It comprises non-inflammatory and inflammatory acne that can affect permanent scars on the skin. It can also be caused by menstruation, improper diet, emotional stress, hot and humid climate, and allergic cosmetics. Acne can be cured by various prescriptions and consuming over-the-counter (OTC) drugs, such as retinoids, antibiotics, salicylic acid, benzoyl peroxide, and oral contraceptives. Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/acne-drugs-market/requestsampleWhat are the growth prospects and trends in the acne drugs industry?
Presently, the rising prevalence of skin conditions among teenagers and adults around the world represents one of the key factors strengthening the market growth. Besides this, the growing awareness among consumers about numerous acne products and treatment options is offering a positive market outlook. Apart from this, the increasing development of effective acne drugs with minimal side effects and high potential is bolstering the growth of the market. Moreover, the wide availability of acne drugs through various distribution channels, such as pharmacies, drug, and online stores, is offering a lucrative growth opportunity to industry investors. Furthermore, key manufacturers are introducing isotretinoin capsules for patients suffering from recalcitrant nodular acne, which is propelling the growth of the market.What is included in market segmentation?
The report has segmented the market into the following categories: Breakup by Acne Type:- Comedonal
- Inflammatory
- Cystic
- Postsurgical/Wound
- Retinoids
- Antibiotics
- Hormonal Agents
- Combination Drugs
- Others
- OTC Drugs
- Prescription Drugs
- Topical
- Oral
- Injectable
- North America
- Asia-Pacific
- Europe
- Latin America
- Middle East and Africa
Who are the key players operating in the industry?
The report covers the major market players including:- Allergan Plc
- Bausch Health Companies Inc.
- Bayer Aktiengesellschaft
- Cipher Pharmaceuticals Inc.
- Galderma Holding SA
- Johnson & Johnson
- Pfizer Inc.
- Reckitt Benckiser Group Plc
- Skinvisible Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Limited
- Teva Pharmaceutical Industries Ltd.